Logo
Secure Registration

International Conference on Neuroscience and Translational Research

ICNTR

26th Dec – 27th Dec 2026 Berlin, Germany

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 16
01 Innovations in Neurotherapeutics +
This track focuses on the latest advancements in neurotherapeutic approaches for treating brain disorders. Emphasis will be placed on novel drug development and innovative treatment modalities.
SDG 3 SDG 4
02 Translational Neuroscience: Bridging Bench and Bedside +
This session explores the methodologies and challenges in translating basic neuroscience discoveries into clinical applications. Participants will discuss successful case studies and strategies for effective translation.
SDG 3 SDG 9
03 Neurobiology of Brain Diseases +
This track delves into the underlying neurobiological mechanisms of various brain diseases, including neurodegenerative disorders and psychiatric conditions. Research findings that elucidate disease pathology will be highlighted.
SDG 3 SDG 4
04 Preclinical Models in Neuroscience Research +
This session will cover the development and application of preclinical models in neuroscience research. Discussions will focus on their relevance and impact on understanding human brain diseases.
SDG 3 SDG 9
05 Clinical Trials in Neuropharmacology +
This track emphasizes the design and implementation of clinical trials aimed at evaluating neuropharmacological interventions. Participants will share insights on regulatory challenges and trial outcomes.
SDG 3 SDG 9
06 Biomarkers in Neuroscience +
This session will focus on the identification and validation of biomarkers for brain diseases. The role of biomarkers in diagnostics, prognosis, and treatment response will be discussed.
SDG 3 SDG 4
07 Experimental Neuroscience Techniques +
This track highlights cutting-edge experimental techniques used in neuroscience research, including imaging and electrophysiological methods. Participants will present novel findings derived from these methodologies.
SDG 3 SDG 4
08 Neuroscience Innovations in Mental Health +
This session addresses innovative approaches in neuroscience aimed at improving mental health outcomes. Topics will include novel therapeutic strategies and the integration of technology in treatment.
SDG 3 SDG 4
09 Neuroinflammation and Brain Health +
This track examines the role of neuroinflammation in various neurological disorders and its implications for brain health. Research on anti-inflammatory strategies and their therapeutic potential will be discussed.
SDG 3 SDG 4
10 Cognitive Neuroscience and Neuroplasticity +
This session explores the relationship between cognitive processes and neuroplasticity in the brain. The impact of neuroplasticity on rehabilitation and recovery from brain injuries will be a key focus.
SDG 3 SDG 4
11 Ethical Considerations in Neuroscience Research +
This track will address the ethical challenges and considerations inherent in neuroscience research and clinical practice. Discussions will include informed consent, patient rights, and the implications of emerging technologies.
SDG 16 SDG 3